France

Sofinnova Partners closes €650M Fund to accelerate Biopharma and MedTech Breakthroughs
Sofinnova Partners, one of Europe’s leading life sciences venture capital firms, has closed Sofinnova Capital XI at €650 million ($750 million) — well above its initial target.

The best Articles in our Network